Wells Fargo’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
84,596
+20,579
| +32% | +$56.2K | ﹤0.01% | 4305 |
|
|
2025
Q1 | $108K | Buy |
64,017
+1,996
| +3% | +$3.35K | ﹤0.01% | 4622 |
|
|
2024
Q4 | $101K | Buy |
62,021
+20,950
| +51% | +$34.1K | ﹤0.01% | 4709 |
|
|
2024
Q3 | $171K | Sell |
41,071
-6,327
| -13% | -$26.3K | ﹤0.01% | 4293 |
|
|
2024
Q2 | $259K | Buy |
47,398
+12,494
| +36% | +$68.2K | ﹤0.01% | 3988 |
|
|
2024
Q1 | $349K | Buy |
34,904
+4,481
| +15% | +$44.8K | ﹤0.01% | 3773 |
|
|
2023
Q4 | $124K | Sell |
30,423
-52,596
| -63% | -$215K | ﹤0.01% | 4371 |
|
|
2023
Q3 | $321K | Sell |
83,019
-9,512
| -10% | -$36.8K | ﹤0.01% | 3759 |
|
|
2023
Q2 | $551K | Buy |
92,531
+8,560
| +10% | +$51K | ﹤0.01% | 3678 |
|
|
2023
Q1 | $275K | Buy |
83,971
+83,764
| +40,466% | +$274K | ﹤0.01% | 3988 |
|
|
2022
Q4 | $818 | Sell |
207
-2,967
| -93% | -$11.7K | ﹤0.01% | 5917 |
|
|
2022
Q3 | $19K | Sell |
3,174
-1,786
| -36% | -$10.7K | ﹤0.01% | 5107 |
|
|
2022
Q2 | $32K | Sell |
4,960
-3,036
| -38% | -$19.6K | ﹤0.01% | 4957 |
|
|
2022
Q1 | $66K | Sell |
7,996
-29,621
| -79% | -$244K | ﹤0.01% | 5201 |
|
|
2021
Q4 | $583K | Buy |
37,617
+37,138
| +7,753% | +$576K | ﹤0.01% | 4247 |
|
|
2021
Q3 | $11K | Sell |
479
-231
| -33% | -$5.31K | ﹤0.01% | 5852 |
|
|
2021
Q2 | $14K | Buy |
710
+492
| +226% | +$9.7K | ﹤0.01% | 5708 |
|
|
2021
Q1 | $7K | Buy |
+218
| New | +$7K | ﹤0.01% | 6056 |
|